The Latin America, Middle East and Africa Rare Diseases Treatment Market would witness market growth of 16% CAGR during the forecast period (2022-2028).
Despite the fact that only a small percentage of patients are affected by specific rare diseases, the market for therapeutics for these conditions is expanding due to radical changes in regulatory frameworks and research and development. Payers and policymakers are thinking about making adjustments to meet the demands of this expanding market and any difficulties it might pose.
Such beneficial government initiatives may aid industry growth over the projected period. Furthermore, companies have launched initiatives like collaborations and partnerships to develop, manufacture, and commercialize products in the market. A large number of rare disease treatment providers are offering various advanced injectables in order to serve the patients better.
As being among the region's most economically developed and diverse markets, the UAE has a strong healthcare infrastructure. The UAE government has made developing a world-class healthcare infrastructure a top priority, and as a result, the sector has developed & grown significantly in recent years. The UAE government has moved quickly to put preventive health measures in place. The UAE's healthcare sector has grown to meet the changing needs of the country's population as well as the country's ambition to become a regional hub for medical tourism.
The Brazil market dominated the LAMEA Rare Diseases Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,855.7 million by 2028. The Argentina market is exhibiting a CAGR of 16.7% during (2022 - 2028). Additionally, The UAE market is poised to grow at a CAGR of 15.7% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on Route of Administration, the market is segmented into Injectable, Oral, and Others. Based on Therapeutic Area, the market is segmented into Cancer, Cardiovascular Conditions, Infectious Diseases, Musculoskeletal Conditions, Endocrine Disorders, Metabolic Disorders, Hematologic Disorders, Neurological Conditions, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Rare Diseases Treatment Market is Predict to reach $255.4 Billion by 2028, at a CAGR of 12.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Merck Group, Bristol Myers Squibb Company, Pfizer, Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited and PTC Therapeutics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Biologics
- Biosimilar
- Small Molecule
By Distribution Channel
- Specialty Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By Route of Administration
By Therapeutic Area
- Cancer
- Cardiovascular Conditions
- Infectious Diseases
- Musculoskeletal Conditions
- Endocrine Disorders
- Metabolic Disorders
- Hematologic Disorders
- Neurological Conditions
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- AbbVie, Inc.
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Novartis AG
- Merck Group
- Bristol Myers Squibb Company
- Pfizer, Inc.
- AstraZeneca PLC
- Takeda Pharmaceutical Company Limited
- PTC Therapeutics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Rare Diseases Treatment Market, by Drug Type
1.4.2 LAMEA Rare Diseases Treatment Market, by Distribution Channel
1.4.3 LAMEA Rare Diseases Treatment Market, by Route of Administration
1.4.4 LAMEA Rare Diseases Treatment Market, by Therapeutic Area
1.4.5 LAMEA Rare Diseases Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Aug) Leading Players
Chapter 4. LAMEA Rare Diseases Treatment Market by Drug Type
4.1 LAMEA Biologics Market by Country
4.2 LAMEA Biosimilar Market by Country
4.3 LAMEA Small Molecule Market by Country
Chapter 5. LAMEA Rare Diseases Treatment Market by Distribution Channel
5.1 LAMEA Specialty Pharmacy Market by Country
5.2 LAMEA Hospital Pharmacy Market by Country
5.3 LAMEA Online Pharmacy Market by Country
Chapter 6. LAMEA Rare Diseases Treatment Market by Route of Administration
6.1 LAMEA Injectable Market by Country
6.2 LAMEA Oral Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Rare Diseases Treatment Market by Therapeutic Area
7.1 LAMEA Cancer Market by Country
7.2 LAMEA Cardiovascular Conditions Market by Country
7.3 LAMEA Infectious Diseases Market by Country
7.4 LAMEA Musculoskeletal Conditions Market by Country
7.5 LAMEA Endocrine Disorders Market by Country
7.6 LAMEA Metabolic Disorders Market by Country
7.7 LAMEA Hematologic Disorders Market by Country
7.8 LAMEA Neurological Conditions Market by Country
7.9 LAMEA Others Market by Country
Chapter 8. LAMEA Rare Diseases Treatment Market by Country
8.1 Brazil Rare Diseases Treatment Market
8.1.1 Brazil Rare Diseases Treatment Market by Drug Type
8.1.2 Brazil Rare Diseases Treatment Market by Distribution Channel
8.1.3 Brazil Rare Diseases Treatment Market by Route of Administration
8.1.4 Brazil Rare Diseases Treatment Market by Therapeutic Area
8.2 Argentina Rare Diseases Treatment Market
8.2.1 Argentina Rare Diseases Treatment Market by Drug Type
8.2.2 Argentina Rare Diseases Treatment Market by Distribution Channel
8.2.3 Argentina Rare Diseases Treatment Market by Route of Administration
8.2.4 Argentina Rare Diseases Treatment Market by Therapeutic Area
8.3 UAE Rare Diseases Treatment Market
8.3.1 UAE Rare Diseases Treatment Market by Drug Type
8.3.2 UAE Rare Diseases Treatment Market by Distribution Channel
8.3.3 UAE Rare Diseases Treatment Market by Route of Administration
8.3.4 UAE Rare Diseases Treatment Market by Therapeutic Area
8.4 Saudi Arabia Rare Diseases Treatment Market
8.4.1 Saudi Arabia Rare Diseases Treatment Market by Drug Type
8.4.2 Saudi Arabia Rare Diseases Treatment Market by Distribution Channel
8.4.3 Saudi Arabia Rare Diseases Treatment Market by Route of Administration
8.4.4 Saudi Arabia Rare Diseases Treatment Market by Therapeutic Area
8.5 South Africa Rare Diseases Treatment Market
8.5.1 South Africa Rare Diseases Treatment Market by Drug Type
8.5.2 South Africa Rare Diseases Treatment Market by Distribution Channel
8.5.3 South Africa Rare Diseases Treatment Market by Route of Administration
8.5.4 South Africa Rare Diseases Treatment Market by Therapeutic Area
8.6 Nigeria Rare Diseases Treatment Market
8.6.1 Nigeria Rare Diseases Treatment Market by Drug Type
8.6.2 Nigeria Rare Diseases Treatment Market by Distribution Channel
8.6.3 Nigeria Rare Diseases Treatment Market by Route of Administration
8.6.4 Nigeria Rare Diseases Treatment Market by Therapeutic Area
8.7 Rest of LAMEA Rare Diseases Treatment Market
8.7.1 Rest of LAMEA Rare Diseases Treatment Market by Drug Type
8.7.2 Rest of LAMEA Rare Diseases Treatment Market by Distribution Channel
8.7.3 Rest of LAMEA Rare Diseases Treatment Market by Route of Administration
8.7.4 Rest of LAMEA Rare Diseases Treatment Market by Therapeutic Area
Chapter 9. Company Profiles
9.1 AbbVie, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Bayer AG
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Novartis AG
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Approval and Trails:
9.5 Merck Group
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Bristol Myers Squibb Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisitions and Mergers:
9.8 AstraZeneca PLC
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. PTC Therapeutics, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Acquisition and Mergers:
TABLE 1 LAMEA Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Rare Disease Treatment Market
TABLE 4 Acquisition and Mergers – Rare Disease Treatment Market
TABLE 5 Approvals and Trials – Rare Disease Treatment Market
TABLE 6 LAMEA Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 7 LAMEA Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 8 LAMEA Biologics Market by Country, 2018 - 2021, USD Million
TABLE 9 LAMEA Biologics Market by Country, 2022 - 2028, USD Million
TABLE 10 LAMEA Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA Small Molecule Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA Small Molecule Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 15 LAMEA Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 16 LAMEA Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 17 LAMEA Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 18 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 19 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 20 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 21 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 22 LAMEA Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 23 LAMEA Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 24 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
TABLE 25 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
TABLE 26 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 27 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 28 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 29 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 30 LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 31 LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 32 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 33 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 34 LAMEA Cardiovascular Conditions Market by Country, 2018 - 2021, USD Million
TABLE 35 LAMEA Cardiovascular Conditions Market by Country, 2022 - 2028, USD Million
TABLE 36 LAMEA Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 37 LAMEA Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 38 LAMEA Musculoskeletal Conditions Market by Country, 2018 - 2021, USD Million
TABLE 39 LAMEA Musculoskeletal Conditions Market by Country, 2022 - 2028, USD Million
TABLE 40 LAMEA Endocrine Disorders Market by Country, 2018 - 2021, USD Million
TABLE 41 LAMEA Endocrine Disorders Market by Country, 2022 - 2028, USD Million
TABLE 42 LAMEA Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 43 LAMEA Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 44 LAMEA Hematologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 45 LAMEA Hematologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 46 LAMEA Neurological Conditions Market by Country, 2018 - 2021, USD Million
TABLE 47 LAMEA Neurological Conditions Market by Country, 2022 - 2028, USD Million
TABLE 48 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 49 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 50 LAMEA Rare Diseases Treatment Market by Country, 2018 - 2021, USD Million
TABLE 51 LAMEA Rare Diseases Treatment Market by Country, 2022 - 2028, USD Million
TABLE 52 Brazil Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 53 Brazil Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 54 Brazil Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 55 Brazil Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 56 Brazil Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 57 Brazil Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 58 Brazil Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 59 Brazil Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 60 Brazil Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 61 Brazil Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 62 Argentina Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 63 Argentina Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 64 Argentina Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 65 Argentina Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 66 Argentina Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 67 Argentina Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 68 Argentina Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 69 Argentina Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 70 Argentina Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 71 Argentina Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 72 UAE Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 73 UAE Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 74 UAE Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 75 UAE Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 76 UAE Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 77 UAE Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 78 UAE Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 79 UAE Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 80 UAE Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 81 UAE Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 82 Saudi Arabia Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 83 Saudi Arabia Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 84 Saudi Arabia Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 85 Saudi Arabia Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 86 Saudi Arabia Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 87 Saudi Arabia Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 88 Saudi Arabia Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 89 Saudi Arabia Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 90 Saudi Arabia Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 91 Saudi Arabia Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 92 South Africa Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 93 South Africa Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 94 South Africa Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 95 South Africa Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 96 South Africa Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 97 South Africa Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 98 South Africa Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 99 South Africa Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 100 South Africa Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 101 South Africa Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 102 Nigeria Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 103 Nigeria Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 104 Nigeria Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 105 Nigeria Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 106 Nigeria Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 107 Nigeria Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 108 Nigeria Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 109 Nigeria Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 110 Nigeria Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 111 Nigeria Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 112 Rest of LAMEA Rare Diseases Treatment Market, 2018 - 2021, USD Million
TABLE 113 Rest of LAMEA Rare Diseases Treatment Market, 2022 - 2028, USD Million
TABLE 114 Rest of LAMEA Rare Diseases Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 115 Rest of LAMEA Rare Diseases Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 116 Rest of LAMEA Rare Diseases Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 117 Rest of LAMEA Rare Diseases Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 118 Rest of LAMEA Rare Diseases Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 119 Rest of LAMEA Rare Diseases Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 120 Rest of LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2018 - 2021, USD Million
TABLE 121 Rest of LAMEA Rare Diseases Treatment Market by Therapeutic Area, 2022 - 2028, USD Million
TABLE 122 Key information – AbbVie, Inc.
TABLE 123 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 124 Key Information – Bayer AG
TABLE 125 Key Information – Novartis AG
TABLE 126 key Information – Merck GrouP
TABLE 127 Key Information – Bristol Myers Squibb Company
TABLE 128 Key Information – Pfizer, Inc.
TABLE 129 KEY INFORMATION – ASTRAZENECA PLC
TABLE 130 Key Information – Takeda Pharmaceutical Company Limited
TABLE 131 Key Information – PTC Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Aug) Leading Players
FIG 5 Recent strategies and developments: Pfizer, Inc.
FIG 6 Recent strategies and developments: PTC Therapeutics, Inc.